EUVIMEDEUVIMED entdecken
Crossref

Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model

Marco Lanzillotta, Peter Macinga, Jakob L Poulsen, Olof Vinge-Holmquist, A Fatih Demirci, Matteo Tacelli, Johanna Backhus, Hana Algül, Clémence Descourvieres, Mariia Kiriukova, Elisabetta Goni, Marcus Hollenbach und 48 weitere

Clinical Gastroenterology and Hepatology · 2026-05 · 24 (5) · 1321-1331

DOI: 10.1016/j.cgh.2025.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-05. Verfasst von Marco Lanzillotta und 59 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy; Università Vita-Salute S…. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Maintenance Chemotherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: United European Gastroenterology, Instytut Pomnik - Centrum Zdrowia Dziecka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Type 1 autoimmune pancreatitis (AIP) is a relapsing remitting disorder that often requires multiple treatment courses. Our aims were to assess the efficacy of maintenance treatment in preventing relapse and to develop the PrescrAIP risk score predicting relapse risk and the benefit of maintenance treatment. METHODS: We retrospectively analyzed patients meeting international diagnostic criteria for type 1 AIP who reached partial or complete remission after initial treatment. The primary outcome was disease relapse, defined as recurrence of symptoms and/or radiologic findings. We developed a multivariable prediction model using Cox proportional hazards regression, performed internal and internal-external validation, and built a predictive nomogram. RESULTS: We included 577 patients (68% male). During a median follow-up of 34 months (interquartile range, 13-69 months), we observed 154 relapses. The overall 3-year relapse risk was 28% (95% confidence interval [CI], 24%-32%), lower in patients receiving maintenance treatment than in those without (22% vs 35%; P 155, but not in those with lower scores. CONCLUSIONS: Maintenance therapy reduced relapse only in patients at high relapse risk. Once externally validated, the PrescrAIP score may guide personalized maintenance treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune PancreatitisMaintenance ChemotherapyHumansMaleFemaleRetrospective StudiesMiddle AgedRecurrenceAdultAgedTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

Autoimmune PancreatitisIgG4Multicenter StudyPersonalized TreatmentPrediction Model

Autor:innen und Institutionen

  • Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: lanzillotta.marco@hsr.i…
  • Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Centre for Pancreatic Diseases, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Digestive Surgery, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
  • Department of Internal Medicine, Marmara University Research and Education Hospital, Istanbul, Turkey.
  • Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Förderung

  • United European Gastroenterology
  • Instytut Pomnik - Centrum Zdrowia Dziecka

Zitieren

APA

Lanzillotta, M., Macinga, P., Poulsen, J. L., Vinge-Holmquist, O., Demirci, A. F., Tacelli, M., Backhus, J., Algül, H., Descourvieres, C., Kiriukova, M., Goni, E., Hollenbach, M., Miksch, R. C., Kunovsky, L., Vujasinovic, M., Nikolic, S., Dickerson, L., Hirth, M., Neurath, M. F., …, & Della-Torre, E. (2026). Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model. Clinical Gastroenterology and Hepatology, 24(5), 1321-1331. https://doi.org/10.1016/j.cgh.2025.09.005

Vancouver

Lanzillotta M, Macinga P, Poulsen JL, Vinge-Holmquist O, Demirci AF, Tacelli M, et al. Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model. Clinical Gastroenterology and Hepatology. 2026;24(5):1321-1331. doi:10.1016/j.cgh.2025.09.005

BibTeX
@article{Lanzillotta2026,
  author = {Lanzillotta, Marco and Macinga, Peter and Poulsen, Jakob L and Vinge-Holmquist, Olof and Demirci, A Fatih and Tacelli, Matteo and Backhus, Johanna and Algül, Hana and Descourvieres, Clémence and Kiriukova, Mariia and Goni, Elisabetta and Hollenbach, Marcus and Miksch, Rainer C and Kunovsky, Lumir and Vujasinovic, Miroslav and Nikolic, Sara and Dickerson, Luke and Hirth, Michael and Neurath, Markus F and Zumblick, Malte and Vila, Josephine and Jalal, Mustafa and Beyer, Georg and Frost, Fabian and Carrara, Silvia and Kala, Zdenek and Jabandziev, Petr and Sisman, Gurhan and Akyuz, Filiz and Capurso, Gabriele and Falconi, Massimo and Arlt, Alexander and Vleggaar, Frank P and Barresi, Luca and Greenhalf, Bill and Czakó, László and Hegyi, Peter and Hopper, Andrew and Nayar, Manu K and Gress, Thomas M and Vitali, Francesco and Schneider, Alexander and Halloran, Chris M and Trna, Jan and Okhlobystin, Alexey V and Dagna, Lorenzo and Cahen, Djuna L and Bordin, Dmitry and Rebours, Vinciane and Mayerle, Julia and Kahraman, Alisan and Rasch, Sebastian and Culver, Emma and Kleger, Alexander and Martínez-Moneo, Emma and Hucl, Tomas and Olesen, Søren S and Bruno, Marco J and Beuers, Ulrich and Della-Torre, Emanuel},
  title = {Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {1321--1331},
  doi = {10.1016/j.cgh.2025.09.005}
}
Kostenlos starten →